Abstract
Glypican-3 (GPC3) is a proteoglycan involved in migration, proliferation and cell survival modulation in several tissues. There are many reports demonstrating a downregulation of GPC3 expression in some human tumors, including mesothelioma, ovarian and breast cancer. Previously, we determined that GPC3 reexpression in the murine mammary adenocarcinoma LM3 cells induced an impairment of their in vivo invasive and metastatic capacities together with a higher susceptibility to in vitro apoptosis. Currently, the signaling mechanism of GPC3 is not clear. First, it was speculated that GPC3 regulates the insulin-like growth factor (IGF) signaling system. This hypothesis, however, has been strongly challenged. Recently, several reports indicated that at least in some cell types GPC3 serves as a selective regulator of Wnt signaling. Here we provide new data demonstrating that GPC3 regulates Wnt pathway in the metastatic adenocarcinoma mammary LM3 cell line. We found that GPC3 is able to inhibit canonical Wnt signals involved in cell proliferation and survival, as well as it is able to activate non canonical pathway, which directs cell morphology and migration. This is the first report indicating that breast tumor cell malignant properties can be reverted, at least in part, by GPC3 modulation of Wnt signaling. Our results are consistent with the potential role of GPC3 as a metastasis suppressor.







Similar content being viewed by others
Change history
09 September 2023
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s10549-023-07123-7
References
Filmus J, Selleck SB (2001) Glypicans: proteoglycans with a surprise. J Clin Invest 108:497–501
Nakato H, Futch TA, Selleck SB (1995) The division abnormally delayed (dally) gene: a putative integral membrane proteoglycan required for cell division patternig during postembryonic development of the nervous system in Drosophila. Development 121:3687–3702
Baeg GH, Lin X, Khare N et al (2001) Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless. Development 126:87–94
Baeg GH, Perrimon N (2000) Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila. Curr Opin Cell Biol 12(5):575–580
Desbordes SC, Sanson B (2003) The glypican Dally-like is required for Hedgehog signalling in the embryonic epidermis of Drosophila. Development 130(25):6245–6255
Habas R, Dawid IB, He X (2003) Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev 17(2):295–309
Kuhl M, Geis K, Sheldahl LC et al (2001) Antagonistic regulation of convergent extension movements in Xenopus by Wnt/beta-catenin and Wnt/Ca2 + signaling. Mech Dev 106(1–2):61–76
Schambony A, Kunz M, Gradl D (2004) Cross-regulation of Wnt signaling and cell adhesion. Differentiation 72(7):307–318
Ilyas M (2005) Wnt signalling and the mechanistic basis of tumour development. J Pathol 205(2):130–144
Pilia G, Hughes-Benzie RM, MacKenzie A et al (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12(3):241–247
Cano-Gauci DF, Song HH, Yang H et al (1999) Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol 146(1):255–264
Dueñas-Gonzalez A, Kaya M, Shi W et al (1998) OCI 5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell-specific manner. J Cell Biol 141:1407–1414
Peters MG, Farias E, Colombo L et al (2003) Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model. Breast Cancer Res Treat 80(2):221–232
Lin H, Huber R, Schlessinger D et al (1999) Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res 59(4):807–810
Murthy SS, Shen T, De Rienzo A et al (2000) Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene 19(3):410–416
Xiang YY, Ladeda V, Filmus J (2001) Glypican-3 expression is silenced in human breast cancer. Oncogene 20(50):7408–7412
Weksberg R, Squire JA, Templeton DM (1996) Glypicans: a growing trend. Nat Genet 12(3):225–227
Song HH, Shi W, Filmus J (1997) OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J Biol Chem 272:7574–7577
Chiao E, Fisher P, Crisponi L et al (2002) Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling. Dev Biol 243(1):185–206
Song HH, Shi W, Xiang YY et al (2005) The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem 280(3):2116–2125
Capurro MI, Shi W, Sandal S et al (2005) Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth. J Biol Chem 280(50):41201–41206
Capurro MI, Xiang YY, Lobe C et al (2005) Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 65(14):6245–6254
De Cat B, Muyldermans SY, Coomans C et al (2003) Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements. J Cell Biol 163(3):625–635
Song HH, Shi W, Xiang YY et al (2005) The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem 280(3):2116–2125
Urtreger A, Ladeda V, Puricelli L et al (1997) Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two murine mammary cell lines. Int J Oncol 11:489–496
Bal de Kier Joffé E, Puricelli L, Vidal MC et al (1983) Characterization of two murine mammary adenocarcinoma tumors with different metastatic ability. J Exp Clin Cancer Res 2:151–160
Mizushima S, Nagata S (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18(17):5322
Filmus J, Shi W, Wong ZM et al (1995) Identification of a new membrane-bound heparan sulphate proteoglycan. Biochem J 311(Pt 2):561–565
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Soriano S, Kang DE, Fu M et al (2001) Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J Cell Biol 152(4):785–794
Coso OA, Chiariello M, Yu JC et al (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81(7):1137–1146
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45
Hwang SG, Yu SS, Lee SW et al (2005) Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway. FEBS Lett 579(21):4837–4842
Wagner EF (2002) Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 61(Suppl 2):ii40–ii42
Veeman MT, Axelrod JD, Moon RT (2003) A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 5(3):367–377
Willipinski-Stapelfeldt B, Riethdorf S, Assmann V et al (2005) Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 11(22):8006–8014
Nobes CD, Hall A (1995) Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 23(3):456–459
Kuhl M, Sheldahl LC, Malbon CC et al (2000) Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem 275(17):12701–12711
Boutros M, Paricio N, Strutt DI et al (1998) Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell 94(1):109–118
Pandur P, Maurus D, Kuhl M (2002) Increasingly complex: new players enter the Wnt signaling network. Bioessays 24(10):881–884
Weeraratna AT, Jiang Y, Hostetter G et al (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1(3):279–288
Tada M, Concha ML, Heisenberg CP (2002) Non-canonical Wnt signalling and regulation of gastrulation movements. Semin Cell Dev Biol 13(3):251–260
Ohkawara B, Yamamoto TS, Tada M et al (2003) Role of glypican 4 in the regulation of convergent extension movements during gastrulation in Xenopus laevis. Development 130(10):2129–2138
Pecina-Slaus N (2003) Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int 3(1):17
Huelsken J, Behrens J (2002) The Wnt signalling pathway. J Cell Sci 115(Pt 21):3977–3978
Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303(5663):1483–1487
Christofori G (2003) Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. Embo J 22(10):2318–2323
Gupta S, Barrett T, Whitmarsh AJ et al (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. Embo J 15(11):2760–2770
Minden A, Lin A, Claret FX et al (1995) Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81(7):1147–1157
Coffey ET, Hongisto V, Dickens M et al (2000) Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons. J Neurosci 20(20):7602–7613
Huang C, Jacobson K, Schaller MD (2004) MAP kinases and cell migration. J Cell Sci 117(Pt 20):4619–4628
Zhang L, Wang W, Hayashi Y et al (2003) A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure. Embo J 22(17):4443–4454
Barr RK, Bogoyevitch MA (2001) The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int J Biochem Cell Biol 33(11):1047–1063
Ip YT, Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10(2):205–219
Xia Y, Karin M (2004) The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol 14(2):94–101
Neilson EG (2006) Mechanisms of disease: Fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol 2(2):101–108
Brabletz T, Hlubek F, Spaderna S et al (2005) Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 179(1–2):56–65
Bafico A, Liu G, Goldin L et al (2004) An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6(5):497–506
Acknowledgements
The work was supported by grants from FONCyT (PICT 14088, Préstamo BID 1728/OC-AR) and from the University of Buenos Aires (UBACyT M068). We would like to give our thanks to Guillermo Peluffo for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Lydia Puricelli, Elisa Bal de Kier Joffé and María Giselle Peters are the members of the National Council of Scientific and Technical Research (CONICET).
About this article
Cite this article
Stigliano, I., Puricelli, L., Filmus, J. et al. RETRACTED ARTICLE: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation. Breast Cancer Res Treat 114, 251–262 (2009). https://doi.org/10.1007/s10549-008-0009-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0009-2